作者
Davood Rostamzadeh, Tohid Kazemi, Zahra Amirghofran, Mahdi Shabani
发表日期
2018/6/3
来源
Expert opinion on therapeutic targets
卷号
22
期号
6
页码范围
487-502
出版商
Taylor & Francis
简介
Introduction: Fc receptor-like (FCRL) molecules, as recently identified members of the immunoglobulin superfamily (IgSF), are preferentially expressed by B-cells. They have variable number of extracellular immunoglobulin-like domains and cytoplasmic activating ITAMs and/or inhibitory ITIMs. FCRL1-5 are dominantly expressed in different stages of B-cells development. But, FCRL6 is preferentially expressed in different subsets of T-cells and NK cells. FCRL1-5 could regulate different features of B-cell evolution such as development, differentiation, activation, antibody secretion and isotype switching.
Areas covered: Improved understanding of FCRL expression may grant B-cells and finally its signaling pathways, alone or in cooperation with other signaling molecules, as interesting new targets for diagnostic, monitoring and immunotherapeutic modalities; although further investigations remain to be defined. Recent …
引用总数
201820192020202120222023202436410996
学术搜索中的文章
D Rostamzadeh, T Kazemi, Z Amirghofran, M Shabani - Expert opinion on therapeutic targets, 2018